Edition:
United States

Advisory Board Co (ABCO.O)

ABCO.O on Nasdaq

41.55USD
19 Jan 2017
Change (% chg)

$0.30 (+0.73%)
Prev Close
$41.25
Open
$41.40
Day's High
$41.80
Day's Low
$41.10
Volume
582,832
Avg. Vol
468,375
52-wk High
$48.86
52-wk Low
$18.87

Latest Key Developments (Source: Significant Developments)

Elliott Associates L.P. says believes securities of Advisory Board are "significantly undervalued and represent an attractive investment opportunity"
Thursday, 12 Jan 2017 08:31am EST 

Advisory Board Co : Elliott Associates L.P. says believes securities of Advisory Board are "significantly undervalued and represent an attractive investment opportunity" . Elliott Associates L.P. reports stake of 8.3 percent in Advisory Board Co as of January 3 .Elliott Associates L.P. says seek to engage in dialogue with advisory board's board of directors regarding "opportunities to maximize shareholder value".  Full Article

Advisory Board Co will reduce workforce by about 220 employees
Tuesday, 3 Jan 2017 05:00pm EST 

Advisory Board Co : The Advisory Board Company aligns health care capabilities to enhance efficiency and drive future growth . Advisory Board Co - will exit certain products and services which do not fully align with its long-term strategy . Advisory board co - education business will not be affected by restructuring plan . Advisory Board Co - will reduce its workforce by about 220 employees, or 5.7% of its total workforce, and close four office locations by year-end 2017 . Expects to incur approximately $20 to $25 million of cash expenses and $25 to $30 million in non-cash charges in 2017 . Advisory Board Co - "while 2016 performance was below our expectations, we do expect to deliver substantial adjusted EBITDA growth in 2017" . Advisory Board Co - full-year 2016 revenue is expected to be approximately $805 to $807 million . Advisory Board Co - workforce reduction, office closures seen resulting in over $25 million reduced annualized operating expenses once plan is fully implemented by 2017 end . Advisory Board - see combination of health care market challenges, strategy portfolio repositioning to cause co to fall short of 2016 revenue growth outlook . Advisory board co says on a preliminary basis, company expects 2017 non-GAAP revenue to be in ranges of $780 to $840 million . Advisory Board Co - sees FY 2016 adjusted EBITDA expected to be $187 to $188 million . Fy2016 revenue view $817.1 million -- Thomson Reuters I/B/E/S.  Full Article

The Advisory Board quarterly earnings per share $0.18
Wednesday, 27 Jul 2016 04:15pm EDT 

Advisory Board Co : Fy2016 revenue view $818.7 million -- Thomson Reuters I/B/E/S . Q2 revenue view $196.5 million -- Thomson Reuters I/B/E/S . Sees FY non-GAAP earnings per diluted share to be in a range of $1.83 to $1.90 . Fy2016 earnings per share view $1.71 -- Thomson Reuters I/B/E/S . The advisory board company reports results for quarter ended June 30, 2016 . Quarterly non-GAAP earnings per share $0.47 . Quarterly earnings per share $0.18 . Sees FY 2016 revenue $817 million to $830 million .Revenue increased 8% to $198.4 million for quarter ended June 30, 2016, up from $183.6 million.  Full Article

Advisory Board Co gives CY 2016 outlook
Tuesday, 23 Feb 2016 04:22pm EST 

Advisory Board Co:Company is providing financial guidance for CY 2016.For CY 2016, the Company expects revenue to be in a range of $810 million to $830 million, adjusted EBITDA to be in a range of $188 million to $195 million, and non-GAAP earnings per diluted share to be in a range of $1.63 to $1.73.  Full Article

Advisory Board Co reaffirms CY 2015 outlook
Thursday, 5 Nov 2015 04:15pm EST 

Advisory Board Co:Reaffirming its annual financial guidance.says for calendar year 2015, Company continues to expect.Sees CY 2015 Adjusted revenue to be in a range of about $780 million to $790 million.Sees CY 2015 Adjusted EBITDA to be in a range of about $170 million to $175 million.Sees CY 2015 Non-GAAP earnings per diluted share to be in a range of about $1.30 to $1.37.  Full Article

Advisory Board Co gives Q3 2015 outlook below analysts' estimates; lowers high end of prior CY 2015 outlook to a range in line with analysts' estimates
Tuesday, 4 Aug 2015 04:25pm EDT 

Advisory Board Co:Expects Q3 2015 adjusted revenue to be in a range of about $187 to $191 million.Expects Q3 2015 Adjusted EBITDA to be in a range of about $27 to $29 million.Expects Q3 2015 Non-GAAP earnings per diluted share to be in a range of about $0.12 to $0.15.Updates CY 2015 adjusted revenue to be in a range of about $780 to $790 million, revised from the previous range of about $780 to $800 million.Updates CY 2015 adjusted EBITDA to be in a range of about $170 to $175 million, revised from the previous range of about $170 to $180 million.Updates CY 2015 Non-GAAP earnings per diluted share to be in a range of about $1.30 to $1.37, revised from the previous range of about $1.30 to $1.43.Q3 2015 revenue of $198 mln, EBITDA of $44 mln and EPS of $0.34 - Thomson Reuters I/B/E/S.CY 2015 revenue of $786 mln, EBITDA of $174 mln and EPS of $1.36 - Thomson Reuters I/B/E/S.  Full Article

Advisory Board Co reaffirms CY 2015 revenue and EBITDA outlook; raises CY 2015 EPS outlook
Tuesday, 5 May 2015 04:17pm EDT 

Advisory Board Co:Reaffirms financial guidance for CY 2015 adjusted revenue and CY 2015 adjusted EBITDA.Continues to expect CY 2015 adjusted revenue to be in a range of about $780 million to $800 million and adjusted EBITDA to be in a range of about $170 million to $180 million.Increases financial guidance for CY 2015 non-GAAP earnings per diluted share.Expects non-GAAP earnings per diluted share for CY 2015 to be in a range of about $1.30 to $1.43, increased from previous range of about $1.22 to $1.35.CY 2015 revenue of $785 million, EBITDA of $173 million and EPS of $1.29 - Thomson Reuters I/B/E/S.  Full Article

Advisory Board Co gives CY 2015 outlook
Wednesday, 11 Feb 2015 04:49pm EST 

Advisory Board Co:Provides financial guidance for CY 2015.Expects CY 2015 adjusted revenue to be in a range of about $780 million to $800 million.Expects CY 2015 adjusted EBITDA to be in a range of about $170 million to $180 million.Expects CY 2015 non-GAAP earnings per diluted share to be in a range of about $1.22 to $1.35.  Full Article

BRIEF-Advisory Board Co comments on Elliott Management's filing

* Says aware of Elliott's filing and Elliott Management's investment in the Advisory Board Company